Jana joined the Newcastle MIC in 2018 as a clinical test evaluation methodologist focused on mixed methods. She has a PhD in Interdisciplinary Statistics, a BSc in Social Research, 13 years of industry experience and several years of teaching and research in academia. From 2010 she worked in higher education organisations as a researcher and lecturer, gaining ample experience in application and management of EU funded Interreg projects. She has a strong background in survey methodology and statistical modelling.

Within the MIC she has developed expertise in care pathway analysis and qualitative research. Her research usually focuses on applying interviews as the dominant technique to gather data from several stakeholders potentially involved in adoption of novel technology. These data are then analysed using qualitative analysis techniques, mainly thematic analysis. During her period at the MIC, she also gained substantial expertise in carrying out systematic reviews and meta-analysis. In addition, she regularly lectures on several modules within the Newcastle University Medical School.

• 2017-2021 │ Wellcome Trust Translation Fund Award “Clinical Validation of Optical Molecular Alveoscopy for the Immediate Bed-Side Diagnosis of Pneumonia in the Intensive Care Unit”. Our role involve qualitative analysis on barriers and facilitators for adoption of the disruptive optical imaging platform to image bacteria in the lungs and provide bedside, real-time, in vivo diagnostic information in UK and US.

• 2018-2019 │ Academic Health Science Network (AHSN) “STOK (Self Testing Own Kidneys) Study”. Our role include qualitative analysis to explore the feasibility of stable post-transplant kidney patients safely testing their kidney function at home.

• 2018-2019 │ Innovate UK and IHG PHARMACO LIMITED “Feasibility of Manufacturing a Reproductive Biomarker Test and Scoping for NHS Adoption in Primary Care” included scoping literature review and care pathway analysis.

• 2017-2021 │ National Institute for Health Research (NIHR) “Antifungal stewardship opportunities with rapid tests for fungal infection in critically ill patients, A-STOP study” included qualitative study protocol. 

• 2018 │ Academic Health Science Network (AHSN) and Gateshead SSGs  “Real World Evaluation of Insulia, Diabetes Management Companion” - development of the project protocol  

• 2017-2022 │ European Institute for Innovation & Technology (EIT) Health and Roche Diagnostics “Transforming influenza management in Europe”. This project aims to improve the inefficient Influenza care pathway and overcome additional post CE-IVD approval obstacles hindering widespread adoption of a new solution. 

• Suklan J, Cheaveau J, Hill S, Urwin SG, Green K, Winter A, Hicks T, Boath AE, Kernohan A, Price DA, Allen AJ, Moloney E, Graziadio S. Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis. Viruses 2021, 13(5), 803.
• Mallett S, Allen AJ, Graziadio S, Taylor SA, Sakai NS, Green K, Suklan J, Hyde C, Shinkins B, Zhelev Z, Peters J, Turner PJ, Roberts NW, di Ruffano LF, Wolff R, Whiting P, Winter A, Bhatnagar G, Nicholson BD, Halligan S. At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data. BMC Medicine 2020, 18(1), 346.
• Graziadio S, Winter A, Lendrem BC, Suklan J, Jones WS, Urwin SG, O'Leary RA, Dickinson R, Halstead A, Kurowska K, Green K, Sims A, Simpson AJ, Power HM, Allen AJ. How to Ease the Pain of Taking a Diagnostic Point of Care Test to the Market: A Framework for Evidence Development. Micromachines 2020, 11(3), 291.
• Hartmann-Boyce J, Gunnell J, Drake J, Otunla A, Suklan J, Schofield E, Kinton J, Inada-Kim M, Hobbs FDR, Dennison P. Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evidence-Based Medicine 2021, 26(4), 195.
• Allen AJ, Gonzalez-Ciscar A, Lendrem C, Suklan J, Allen K, Bell A, Baxter F, Crulley S, Fairlie L, Hardy D, Johnston L, McKenna J, Richards N, Shovlin G, Simmister C, Waugh S, Woodsford P, Graziadio S, Power M, Simpson AJ, Kumar P, Eastham K, Brodlie M. Diagnostic and economic evaluation of a point-of-care test for respiratory syncytial virus. ERJ Open Research 2020, 6(3), 00018-2020.
• Al-Omari B, McMeekin P, Allen AJ, Akram AR, Graziadio S, Suklan J, Jones WS, Lendrem BC, Winter A, Cullinan M, Gray J, Dhaliwal K, Walsh TS, Craven TH. Systematic review of studies investigating ventilator associated pneumonia diagnostics in intensive care. BMC Pulmonary Medicine 2021, (21), 196.
• Jones WS, Rice S, Power HM, Maniatopoulos G, Suklan J, Beyer F, Wilcox MH, Permain M, Simpson AJ, Price DA, Allen AJ. Cost consequences for the NHS of using a two-step testing method for the detection of Clostridium difficile with a point of care, polymerase chain reaction test as the first step. Diagnostics 2020, 10(10), 819.